LGM
SPRB

Logos Global Management’s Spruce Biosciences SPRB Stock Holding History

Logos Global Management’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,333
Closed -$1.1M – 49
2022
Q4 		$1.1M Hold
13,333
– – 0.13% 37
2022
Q3 		$1.37M Hold
13,333
– – 0.17% 34
2022
Q2 		$1.74M Hold
13,333
– – 0.32% 22
2022
Q1 		$2.01M Sell
13,333
-1,334
-9% -$248K 0.26% 34
2021
Q4 		$4.91M Buy
+14,667
New +$4.37M 0.51% 44

Other funds holding SPRB

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Logos Global Management's SPRB Position: Q1 2023 in Review

Logos Global Management sold out of Spruce Biosciences (SPRB) in Q1 2023, closing a stake of 13,333 shares — an estimated $1.1M sold.

Logos Global Management first reported a position in SPRB in Q4 2021 and held it in 5 quarters. The position peaked at $4.91M in Q4 2021. 44 funds tracked by Wall St. Rank hold SPRB as of Q1 2023.

  • Logos Global Management reported no remaining Spruce Biosciences position as of Q1 2023 after selling out during the quarter.
  • Logos Global Management sold 13,333 Spruce Biosciences shares in Q1 2023, an estimated $1.1M.
  • Logos Global Management first reported a position in Spruce Biosciences in Q4 2021 and held it in 5 quarters.
  • Logos Global Management's Spruce Biosciences position peaked at $4.91M in Q4 2021.
  • 44 funds tracked by Wall St. Rank held Spruce Biosciences as of Q1 2023.

Based on Logos Global Management's 13F filing for Q1 2023, filed 15 May 2023.